Mesenchymal Stem Cells (MSCs) for Respiratory Diseases: Hope for Lung Regeneration | #mesenchymal Stem Cells (MSCs) Market

Other

Mesenchymal Stem Cells (MSCs) for Respiratory Diseases: Hope for Lung Regeneration

The Global Mesenchymal Stem Cells (MSCs) Market had a size of USD 3.01 billion in 2022 and is projected to reach USD 86.28 billion by 2032, with a compound annual growth rate (CAGR) of 12% during the forecast period.

Non-Vascular Stents for Airway Management: Advancements in Respiratory Care | #non-Vascular Stents Market

Other

Non-Vascular Stents for Airway Management: Advancements in Respiratory Care

The Global Non-Vascular Stents Market reached a size of USD 1227.66 million in 2022 and is projected to reach USD 1904.5 million by 2032, with a revenue CAGR of 5% during the forecast period.

Increasing Productivity and Accuracy: How LIMS Optimizes Laboratory Operations | #laboratory Informatics Market # Laboratory Information Management Systems

Other

Increasing Productivity and Accuracy: How LIMS Optimizes Laboratory Operations

The Laboratory Information Management Systems is experiencing significant growth, with the global market size reaching USD 3.68 billion in 2022 and projected to reach USD 5.71 billion by 2032.

Future Trends in Cardiac Resynchronization Therapy (CRT) Devices | #implantable Cardiac Rhythm Management (ICRM) Devices Market # Cardiac Resynchronization Therapy (CRT) Devices

Other

Future Trends in Cardiac Resynchronization Therapy (CRT) Devices

The global Cardiac Resynchronization Therapy (CRT) Devices Market was valued at USD 15.87 billion in 2022 and is projected to reach USD 22.98 billion by 2032, with a rapid revenue CAGR of 4.2% during the forecast period.

Beyond Birth Control: Additional Benefits of Combined Hormonal Contraceptives | #hormonal Contraceptive Market # Combined Hormonal Contraceptive Market

Other

Beyond Birth Control: Additional Benefits of Combined Hormonal Contraceptives

The global Combined Hormonal Contraceptive Market, which are methods of birth control that act on the endocrine system, was valued at USD 22.64 billion in 2022.